Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PLP1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PLP1 is a protein involved in neurodegeneration research. Key relationships include: activates, associated with, expressed in. Associated with ALS, Als, Alzheimer. Connected to 47 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | PLP1 |
| Protein Family | Proteolipid protein family |
| Function | PLP1 is essential for multiple aspects of CNS myelination: |
| Primary Expression | CNS (not PNS) |
| Subcellular Localization | Myelin sheath, oligodendrocyte plasma membrane |
| Molecular Weight | 30 kDa |
| Amino Acids | 35 aa |
| Pathways | Phagocytosis |
| UniProt ID | [P60228](https://www.uniprot.org/uniprot/P60228) |
| GeneCards | PLP1 |
| Human Protein Atlas | PLP1 |
| Prenatal | Low expression in oligodendrocyte progenitor cells |
| Postnatal | Dramatic increase during active myelination (first 3-6 months in humans) |
| Adult | Sustained expression for myelin maintenance |
| Regional | Highest expression in cerebral white matter, corpus callosum, internal capsule, and spinal cord |
| Associated Diseases | ALS, Alzheimer, dementia, Ms, myelin dysfunction, Parkinson |
| Known Drugs/Compounds | CURCUMIN, RESVERATROL |
| Interactions | ALZHEIMER, ALZHEIMER'S DISEASE, AMPK, AND, APOE, App |
| KG Connections | 207 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PLP1["PLP1"]
Pelizaeus_Merzbacher_disease{"Pelizaeus-Merzbacher disease"}
PLP1 -->|"causes"| Pelizaeus_Merzbacher_disease
Dementia{"Dementia"}
PLP1 -->|"activates"| Dementia
Als{"Als"}
PLP1 -->|"activates"| Als
Alzheimer{"Alzheimer"}
PLP1 -->|"activates"| Alzheimer
Parkinson{"Parkinson"}
PLP1 -->|"activates"| Parkinson
Ms{"Ms"}
PLP1 -->|"activates"| Ms
ALS{"ALS"}
PLP1 -->|"activates"| ALS
Phagocytosis(["Phagocytosis"])
PLP1 -->|"activates"| Phagocytosis
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
PLP1 -->|"activates"| ALZHEIMER_S_DISEASE
MBP["MBP"]
PLP1 -->|"activates"| MBP
HSPA1A["HSPA1A"]
PLP1 -->|"activates"| HSPA1A
MSR1["MSR1"]
PLP1 -->|"activates"| MSR1
MBP -->|"associated with"| PLP1
MOG["MOG"]
MOG -->|"associated with"| PLP1
MYELIN["MYELIN"]
MYELIN -->|"associated with"| PLP1
OLIGODENDROCYTE["OLIGODENDROCYTE"]
OLIGODENDROCYTE -->|"associated with"| PLP1
HSPA1A -->|"activates"| PLP1
MBP -->|"activates"| PLP1
MSR1 -->|"activates"| PLP1
GENES["GENES"]
GENES -->|"activates"| PLP1
MBP -->|"co discussed"| PLP1
MICROGLIA["MICROGLIA"]
MICROGLIA -->|"co discussed"| PLP1
MYELIN -->|"co discussed"| PLP1
ALZHEIMER["ALZHEIMER"]
ALZHEIMER -->|"associated with"| PLP1
style PLP1 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Pelizaeus-Merzbacher disease | causes | disease | 0.95 |
| Parkinson's Disease Dementia | upregulates | disease | 0.80 |
| PSEN2 | regulates | gene | 0.70 |
| ALS | activates | disease | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| RESVERATROL | interacts_with | drug | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Ms | causes | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| MAG | inhibits | gene | 0.60 |
| OLIG1 | inhibits | gene | 0.60 |
| Neural Progenitor | inhibits | cell_type | 0.60 |
| SOD1 | targets | gene | 0.60 |
| PRKDC | activates | gene | 0.60 |
| SLC17A6 | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| TRPM2 | activates | gene | 0.60 |
| ULK1 | activates | gene | 0.60 |
| Phagocytosis | activates | pathway | 0.60 |
| Immune Response | expressed_in | pathway | 0.60 |
| Ras | inhibits | protein | 0.60 |
| axonal ATP levels | modulates | process | 0.60 |
| App | inhibits | protein | 0.60 |
| compound action potential | associated_with | process | 0.60 |
| spastic paraplegia | implicated_in | disease | 0.60 |
| myelin structural integrity | contributes_to | process | 0.60 |
| MBP | inhibits | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| MSR1 | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| MOBP | activates | gene | 0.60 |
| Oligodendrocyte | activates | cell_type | 0.60 |
| Microglia | activates | cell_type | 0.60 |
| AND | inhibits | gene | 0.60 |
| Myelination | causes | pathway | 0.60 |
| Sphingolipid | causes | pathway | 0.60 |
| Myelination | inhibits | pathway | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURONS | activates | cell_type | 0.70 |
| DOPAMINERGIC | activates | cell_type | 0.70 |
| APP | activates | gene | 0.70 |
| CX3CR1 | associated_with | gene | 0.70 |
| MAPT | regulates | gene | 0.70 |
| GRIN2B | regulates | gene | 0.70 |
| GRIN1 | regulates | gene | 0.70 |
| APP | regulates | gene | 0.70 |
| IDE | regulates | gene | 0.70 |
| MYELIN | associated_with | gene | 0.65 |
| OLIGODENDROCYTE | associated_with | concept | 0.65 |
| OLIGODENDROCYTES | causes | cell_type | 0.65 |
| PARKINSON'S DISEASE | causes | disease | 0.65 |
| PARKIN | causes | gene | 0.65 |
| MBP | associated_with | gene | 0.65 |
| MOG | associated_with | gene | 0.65 |
| NEURODEGENERATION | causes | disease | 0.65 |
| NEURODEGENERATION | inhibits | disease | 0.65 |
| PARKINSON | causes | disease | 0.65 |
| PARKINSON'S | causes | disease | 0.65 |
| CURCUMIN | interacts_with | drug | 0.65 |
| ST3GAL5 | inhibits | gene | 0.60 |
| MBP | inhibits | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| MICROGLIA | co_discussed | gene | 0.60 |
| MYELIN | co_discussed | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | activates | pathway | 0.60 |
| OLIGODENDROCYTES | expresses | cell_type | 0.60 |
| MBP | regulates | entity | 0.60 |
| PD | expresses | gene | 0.60 |
| AND | activates | gene | 0.60 |
| MOBP | activates | gene | 0.60 |
| OLIGODENDROCYTE | causes | gene | 0.60 |
| AND | causes | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| MICROGLIA | causes | gene | 0.60 |
| ASTROCYTE | causes | gene | 0.60 |
| MYELIN | causes | gene | 0.60 |
| MICROGLIA ACTIVATION | causes | gene | 0.60 |
| OLIGODENDROCYTE | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| APP | causes | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| ASTROCYTE | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-23 | 8 hypotheses Top: 0.680
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity